Bad things happen in the basal layer KLF4 and squamous cell carcinoma

Cancer Biology and Therapy

Volumn 7, Issue 5, 2008, Pages 783-785

  Jiang, Wen ^a   Lobo Ruppert, Susan M ^a,b   Ruppert, J Michael ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Skin; Squamous cell carcinoma; Tumor initiation; Tumor progression

Indexed keywords

KRUPPEL LIKE FACTOR 4; PROTEIN P53; ZINC FINGER PROTEIN; KRUPPEL LIKE FACTOR;

ACTINIC KERATOSIS; BASAL CELL; CANCER GROWTH; CANCER STEM CELL; EMBRYO DEVELOPMENT; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALIGNANT TRANSFORMATION; NONHUMAN; NORTHERN BLOTTING; NOTE; ONCOGENE; PLURIPOTENT STEM CELL; PRECANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA ANALYSIS; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; TRANSCRIPTION REGULATION; UPREGULATION; X CHROMOSOME; ANIMAL; CELL DIFFERENTIATION; CELL NUCLEUS; DISEASE COURSE; GENE EXPRESSION REGULATION; METABOLISM; METASTASIS; MOUSE; SKIN TUMOR; TRANSGENIC MOUSE; TUMOR CELL LINE;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL NUCLEUS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, TRANSGENIC; NEOPLASM METASTASIS; SKIN NEOPLASMS;

EID: 56149089924     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.7.5.6110     Document Type: Note

References (19)

1. Jonason AS, Kunala S, Price GJ, Restifo RJ, Spinelli HM, Persing JA, Leffell DJ, Tarone RE, Brash DE. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci USA 1996; 93:14025-9.
2. Fuchs E, Raghavan S. Getting under the skin of epidermal morphogenesis. Nat Rev Genet 2002; 3:199-209.
3. Segre JA, Bauer C, Fuchs E. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat Genet 1999; 22:356-60.
4. Garrett-Sinha LA, Eberspaecher H, Seldin MF, de Crombrugghe B. A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells. J Biol Chem 1996; 271:31384-90.
5. Shields JM, Christy RJ, Yang VW. Identification and characterization of a gene encoding a gut-enriched Krüppel-like factor expressed during growth arrest. J Biol Chem 1996; 271:20009-17.
6. Foster KW, Ren S, Louro ID, Lobo Ruppert SM, McKie Bell P, Grizzle W, Hayes MR, Broker TR, Chow LT, Ruppert JM. Oncogene expression cloning by retroviral transduction of adenovirus E1a-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF. Cell Growth Differ 1999; 10:423-34.
7. Rowland BD, Bernards R, Peeper DS. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol 2005; 7:1074-82.
8. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126:663-76.
9. Huang CC, Liu Z, Li X, Bailey SK, Nail CD, Foster KW, Frost AR, Ruppert JM, Lobo Ruppert SM. KLF4 and PCNA identify stages of tumor initiation in a conditional model of cutaneous squamous epithelial neoplasia. Cancer Biology and Therapy 2005; 4:1401-8.
10. Foster KW, Liu Z, Nail CD, Li X, Fitzgerald TJ, Bailey SK, Frost AR, Louro ID, Townes TM, Paterson AJ, Kudlow JE, Lobo Ruppert SM, Ruppert JM. Induction of KLF4 in basal keratinocytes blocks the proliferation- differentiation switch and initiates squamous epithelial dysplasia. Oncogene 2005; 24:1491-500.
11. Brash DE. Roles of the transcription factor p53 in keratinocyte carcinomas. Br J Dermatol 2006; 154:8-10.
12. Backvall H, Stromberg S, Gustafsson A, Asplund A, Sivertsson A, Lundeberg J, Ponten F. Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma. Exp Dermatol 2004; 13:643-50.
13. Donehower LA. The p53-deficient mouse: a model for basic and applied cancer studies. Semin Cancer Biol 1996; 7:269-78.
14. Kinzler KW, Vogelstein B. Cancer-susceptibility genes: gatekeepers and caretakers. Nature 1997; 386:761.
15. Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 2001; 29:418-25.
16. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 356:215-21.
17. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT, Weinberg RA. Tumor spectrum analysis in p53-mutant mice. Curr Biol 1994; 4:1-7.
18. Okorokov AL, Sherman MB, Plisson C, Grinkevich V, Sigmundsson K, Selivanova G, Milner J, Orlova EV. The structure of p53 tumour suppressor protein reveals the basis for its functional plasticity. EMBO J 2006; 25:5191-200.
19. Chen ZY, Wang X, Zhou Y, Offner G, Tseng CC. Destabilization of Kruppel-like factor 4 protein in response to serum stimulation involves the ubiquitin-proteasome pathway. Cancer Res 2005; 65:10394-400.